Straits Times Index
3,385.93 +1.64 (+0.05%) S&P 500
4,136.48 -43.28 (-1.04%) Dow
33,926.01 -127.89 (-0.38%) Nasdaq
12,006.96 -193.84 (-1.59%) BTC-USD
22,845.25 -561.90 (-2.40%) CMC Crypto 200
524.82 -12.04 (-2.24%)
ABBV Jan 2025 110.000 call
- Motley Fool
2 Stocks Down More Than 6% to Buy Right Now
In fact, two stocks that outperformed the S&P 500 last year are now down more than 6% since the start of the year: Johnson & Johnson (NYSE: JNJ) and AbbVie (NYSE: ABBV).. Motley Fool contributors Adria Cimino and Keith Speights talk about why these two stocks actually make great buys right now. Adria Cimino (Johnson & Johnson): J&J may have disappointed investors when it reported fourth-quarter earnings on Jan. 24.
- Motley Fool
3 Unstoppable Dividend Stocks to Buy in February
Any time is a good time to buy solid dividend stocks. Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Johnson & Johnson (NYSE: JNJ). David Jagielski (Abbott Laboratories): One dividend stock that should be attractive to long-term investors is Abbott Laboratories.
- Zacks
AbbVie Q4 Preview: What's in Store?
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
